Paper41369876
Thermal Versus Ultrasound Inactivation of Bifidobacterium animalis subsp. lactis BB-12: Functional Implications for Postbiotics.
Marsak N and 3 others. Probiotics Antimicrob Proteins, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Thermal Versus Ultrasound Inactivation of Bifidobacterium animalis subsp. lactis BB-12: Functional Implications for Postbiotics. Papers, record 41369876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41369876
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Thermal Versus Ultrasound Inactivation of Bifidobacterium animalis subsp. lactis BB-12: Functional Implications for Postbiotics.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bifidobacterium animalis | Major topic |
| Probiotics | Major topic |
| Bifidobacterium | Major topic |
| Hot Temperature | |
| Microbial Viability | |
| Ultrasonic Waves | |
| Lacticaseibacillus casei | |
| Fatty Acids, Volatile |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 122Z351 | The Scientific and Technological Research Council of Turkey (TÜBİTAK) | PubMed |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37851615 | Limosilactobacillus fermentum HF06-derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis. | J Sci Food Agric | 2024 | https://conductscience.org/library/papers/37851615 | PubMed |
| 2 | 36741903 | Real-time polymerase chain reaction methods for strain specific identification and enumeration of strain Lacticaseibacillus paracasei 8700:2. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36741903 | PubMed |
| 3 | 30036977 | Study of the In Vitro Antagonistic Activity of Various Single-Strain and Multi-Strain Probiotics against Escherichia coli. | Int J Environ Res Public Health | 2018 | https://conductscience.org/library/papers/30036977 | PubMed |
| 4 | 33575277 | Comparative Studies of Inhibitory and Antioxidant Activities, and Organic Acids Compositions of Postbiotics Produced by Probiotic Lactiplantibacillus plantarum Strains Isolated From Malaysian Foods. | Front Vet Sci | 2020 | https://conductscience.org/library/papers/33575277 | PubMed |
| 5 | 32550113 | Promising discovery of beneficial Escherichia coli in the human gut. | 3 Biotech | 2020 | https://conductscience.org/library/papers/32550113 | PubMed |
| 6 | 31000276 | In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. | Food Res Int | 2019 | https://conductscience.org/library/papers/31000276 | PubMed |
| 7 | 38216004 | Paraprobiotic and postbiotic forms of Bacillus siamensis improved growth, immunity, liver and intestinal health in Lateolabrax maculatus fed soybean meal diet. | Fish Shellfish Immunol | 2024 | https://conductscience.org/library/papers/38216004 | PubMed |
| 8 | 35208844 | Lactic Acid Bacteria Isolated from Fresh Vegetable Products: Potential Probiotic and Postbiotic Characteristics Including Immunomodulatory Effects. | Microorganisms | 2022 | https://conductscience.org/library/papers/35208844 | PubMed |
| 9 | 27664734 | Bifidobacteria-Insight into clinical outcomes and mechanisms of its probiotic action. | Microbiol Res | 2016 | https://conductscience.org/library/papers/27664734 | PubMed |
| 10 | 31778135 | Depolymerized RG-I-enriched pectin from citrus segment membranes modulates gut microbiota, increases SCFA production, and promotes the growth of Bifidobacterium spp., Lactobacillus spp. and Faecalibaculum spp. | Food Funct | 2019 | https://conductscience.org/library/papers/31778135 | PubMed |
| 11 | 31547172 | Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31547172 | PubMed |
| 12 | 16971641 | Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. | J Clin Microbiol | 2006 | https://conductscience.org/library/papers/16971641 | PubMed |
| 13 | 27682233 | The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®). | Microorganisms | 2014 | https://conductscience.org/library/papers/27682233 | PubMed |
| 14 | 23384878 | Bacteriocin production by Bifidobacterium spp. A review. | Biotechnol Adv | 2013 | https://conductscience.org/library/papers/23384878 | PubMed |
| 15 | 32621828 | New insights in enumeration methodologies of probiotic cells in finished products. | J Microbiol Methods | 2020 | https://conductscience.org/library/papers/32621828 | PubMed |
| 16 | 36379940 | Stronger gut microbiome modulatory effects by postbiotics than probiotics in a mouse colitis model. | NPJ Sci Food | 2022 | https://conductscience.org/library/papers/36379940 | PubMed |
| 17 | 34444974 | Bifidobacterium animalis subsp. lactis BB-12 Protects against Antibiotic-Induced Functional and Compositional Changes in Human Fecal Microbiome. | Nutrients | 2021 | https://conductscience.org/library/papers/34444974 | PubMed |
| 18 | 21324052 | Assessing the effect of different ultrasonic frequencies on bacterial viability using flow cytometry. | J Appl Microbiol | 2011 | https://conductscience.org/library/papers/21324052 | PubMed |
| 19 | 19529931 | Quantification of live and dead probiotic bacteria in lyophilised product by real-time PCR and by flow cytometry. | Appl Microbiol Biotechnol | 2009 | https://conductscience.org/library/papers/19529931 | PubMed |
| 20 | 19331702 | Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial. | Br J Nutr | 2009 | https://conductscience.org/library/papers/19331702 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42846910 | Paraprobiotics Derived From Bifidobacterium animalis Subsp. LactisBB-12 Attenuates Indomethacin-Induced Gastric Ulcer by Inhibiting the PANoptosis Pathway. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42846910 | PubMed |
| 42529159 | Postbiotics in Food Systems: Components, Production Methods, Food Applications, Functional Properties, and Technological Challenges. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42529159 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41369876
GET https://conductscience.org/api/papers/v1/41369876/references?page=2